Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Iloprost in PH-COPD
NCT01437878Phase 2Terminated
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Mar 2012
- Primary completion
- Nov 2012
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 2 trial of iloprost in pulmonary hypertension (PH), sponsored by Actelion Pharmaceuticals Ltd. Started Mar 2012; status: terminated.
02
Drugs
iloprost
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01437878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01437878.